This symposium will examine the recent advances that directly affect daily clinical management of patients with epilepsy in the outpatient setting. This will include how to predict and avoid major drug interactions, including many clinical pearls; how to choose and use wearable devices to monitor seizure activity and possibly lower the risk of SUDEP; the latest on cannabidiol and how to discuss medical marijuana with patients; and the latest on emerging rapidly-acting formulations designed for home use in seizure emergencies, with the goal of aborting seizure clusters and preventing status epilepticus, injuries, and emergency department visits.
Learning Objectives
Following participation in this activity, learners will be able to:
Introduction: Lawrence J. Hirsch, MD
Polypharmacy: Predictable and Unpredictable Interactions: Dean K. Naritoku, MD
Improving Measurements of Seizure Control, Including Use of Wearables: Tobias Loddenkemper, MD
Cannabidiol and Medical Marijuana: Use, Misuse, and Patient Self-medication: Tyler E. Gaston, MD
Towards Self-management of Acute Seizures: Expanding Out-of-Hospital Treatment Options: James C. Cloyd, PharmD
Conclusions, Q&A Panel: Timothy A. Simeone, MD
- Identify and prevent predictable drug interactions
- Examine how to use wearable devices to help assess seizure frequency and improve patient safety
- Improve effectiveness of conversations about medical marijuana and learn the current state of knowledge of related products
- Increase use of seizure-emergency action plans, including use of new formulations for rapid efficacy
Program
Co-chairs: Lawrence J. Hirsch, MD, and Timothy A. Simeone, MDIntroduction: Lawrence J. Hirsch, MD
Polypharmacy: Predictable and Unpredictable Interactions: Dean K. Naritoku, MD
Improving Measurements of Seizure Control, Including Use of Wearables: Tobias Loddenkemper, MD
Cannabidiol and Medical Marijuana: Use, Misuse, and Patient Self-medication: Tyler E. Gaston, MD
Towards Self-management of Acute Seizures: Expanding Out-of-Hospital Treatment Options: James C. Cloyd, PharmD
Conclusions, Q&A Panel: Timothy A. Simeone, MD